Blue Omega is a new vegetarian source of Omega 3 oil with a high content of eicosapentaenoic acid (EPA) bound to polar-lipids (phospholipids and glycolipids) providing the health benefits of EPA with an improved digestibility.
An encapsulated product, easy to consume. A package of 60 capsules containing 500 mg. of product per capsule. Recommended doses: 3-4 capsules daily.
|High Bio-availability||Best absorption of Omega 3s|
|Antioxidant Protection||Contains naturally Vitamin E (α-tocopherol), Hidroxitirosol and Corotenoids such as β-carotene that help to protect the body's cells from free radical damage. And natural Phytosterols which reduces cholesterol and indirectly helps to prevent cardiovascular disease|
|Healthy||Omega 3 EPA supports the cardiovascular functions, nerve and immune system function and also neurotransmission|
|For Vegans||Vegetable origin that can be consumed by vegans and vegetarians in contrast to other Omega 3 Oils available in the market|
|Odorless||Thanks to the natural antioxidants present in the product there is no a rancid smell as happens with other market options|
|Sustainability||The environmental sustainability of our process is guaranteed in contrast to other Omega 3 sources|
|Blue Omega||Is guarantee of sustainability and quality|
|Composition||g / 100g||Per capsule (mg.)|
|Total Omega 3||20,0||100,0|
*Energy value: 850 Kcal/100g
A high percentage of Omega 3 Eicosapentaenoic Acid present in our oil is linked to polar lipids (phospholipids and glycolipids) improving their digestibility and health benefits in comparison with Other Omega 3 oils.
One of the most important factors that contribute to the Omega 3 efficiency as a potential healthy compound is its bioavailability. The term bioavailability generally designates the capacity of our body to digest these compounds.
The digestibility of Omega 3 and, therefore, its bio-assimilation, depends on the type of molecules in which they are bound. The most common structural form in which Omega 3 can be found on the market is in ethyl esters and triglycerides. Those are not so easily bio-assimilable as polar lipids, proven by several scientific studies. In fact, many lipids contained in food, need to be converted during the digestive process to compound polar lipids wich are more bio-assimilable.
Contain Antioxidants as Vitamin E (a-Tocopherol), Hidroxitirosol and Pigments such as β-carotene, that help to protect the body's cells from free radical damage and Natural Phytosterols which reduce Cholesterol and indirectly help to prevent cardiovascular disease. Request a product datasheet for all nutritional details.
Cardiovascular Disease (CVD): The World Health Organization has recognized connections between Omega 3 and decreased risks of CVD. EPA is good for the heart's health.
Atherosclerosis: Omega 3 Polyunsaturated Fatty Acids such as EPA and Phytosterols can modulate the mechanisms of development and progression of atherosclerosis and helps control the cholesterol levels.
Anti-inflammatory effect: Because of its capacity to reduce inflammation, EPA protects against illnesses related to an inflammatory etiology such us: diabetes, heart disease, and metabolic syndrome.
More benefits: Omega 3 improves the immunological system. the reproductive system, skin, moods and others.
Recently several farm-grown algae announce the algae production to obtain Omega 3 oil as alternative as fish and krill oil. But the current algae production is in open ponds with the limitations that this entails: low yield, limited production, higher risk of contamination, large evaporation (100 m3/day/hectare), large cultivation area, poor light utilization, less yield CO2 absorption.
BASM Blue technology uses vertical, closed bio-reactors with a specific shape that fully automatizes the production process in an aseptic atmosphere, maintaining high quality and homogeneous products throughout the year. This means a controlled environment for best growing conditions that guarantee good production and quality on a large scale all the time.
Blue Omega does not in any way deplete marine animal population or threaten the delicate eco-balance in our oceans.Marine animals, specifically fish and krill, currently represent the main sources for nutritional Omega 3 supplements. Fish oil is the major source for natural (triglyceride) and processed (ethyl-ester) forms of Omega 3 fatty acids (EPA and DHA). Recently, concerns have been raised regarding the sustainability of global fish populations, as pollution and over-harvesting have led to a constant decline in fish population world-wide. In addition, fish oil faces potential contamination as a result of environmental contaminants consumed by the fish.
Krill oil is currently the major source for high bioavailability polar-lipid Omega 3 oil and is extracted from a specific species of krill, Euphausia superba (Antarctic krill). Krill is considered by many scientists to play a key role in the marine Antarctic ecosystem, serving as the main food source for animals such as penguins, seals and whales as well as sea-birds and fish.
One of the advantages of our Omega 3 is that, it is a rich oil with a high EPA content opposed to the DHA ratio present in other oils rich in Omega 3 on the market. Most researchers have attributed beneficial effects to the ω-3 fatty acids but the effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are not differentiated in most studies. Although EPA and DHA are both long chain polyunsaturated fatty acids (EPA, C20:5n3; DHA, C22:6n3), the molecules are often reported to produce biochemical and physiological responses that are qualitatively and quantitatively different to each other.
Short term trials in humans have shown that EPA significantly reduces the levels of plasma triglycerides and may increase the levels of high density lipoproteins. The results of evaluations of EPA's use in patients with renal disorders, mild hypertension, inflammatory disorders or hyperlipidemia have been promising. In fact, JELIS a large scale clinical trial that investigated the effects of eicosapentaenoic acid (EPA) on coronary artery disease (CAD) shows as EPA is a promising treatment for prevention of major coronary events and especially non-fatal coronary events. It should be emphasized that EPA's potential antithrombotic and antiatherogenic effects probably operate independently from any effect on serum cholesterol levels.
On the other hand, recent analysis of the effect of Eicosapentaenoic acid (EPA) in clinical trials in depression indicates that the ratio of the constituent fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) may determine the effectiveness of the supplements.
"Omega 3 EPA helps with cardiovascular function, nervous system function, immunity and neurotransmission"